Nderitu, Paul
Nunez do Rio, Joan M.
Webster, Ms Laura
Mann, Samantha S.
Hopkins, David
Cardoso, M. Jorge
Modat, Marc
Bergeles, Christos
Jackson, Timothy L.
Funding for this research was provided by:
Diabetes UK (20/0006144)
Article History
Received: 8 February 2022
Accepted: 24 June 2022
First Online: 1 July 2022
Competing interests
: P Nderitu, JM Nunez do Rio, L Webster, SS Mann, D Hopkins, MJ Cardoso, M Modat, C Bergeles has no conflicts of interest to declare. T Jacksons’ employer (King’s College Hospital) receives funding for participants enrolled on commercial clinical trials of diabetic retinopathy including THR149-002 (sponsor: OXURION), NEON NPDR (sponsor: BAYER), RHONE-X (sponsor: ROCHE) and ALTIMETER (sponsor: ROCHE). He has been paid for an expert clinical opinion by Kirkland and Ellis Solicitors, acting for REGENERON.